Regression of hepatocellular carcinoma during vitamin K administration

doi:10.3748/wjg.v11.i42.6722

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2614)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

331

HTML

2134

Figures (1-3)

149

Sum=2614

Nov 14, 2005 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Nov 14, 2005; 11(42): 6722-6724
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6722

Full Size Figure Download Figure

Figure 2 Enhancement of peripheral portion of tumor during early arterial phase (A) and hypoattenuation during portal phase (B) as well as remarkable tumor regression and no enhancement during early arterial phase (C) and portal phase (D) 5 mo after administration of vitamin K.

Citation: Nouso K, Uematsu S, Shiraga K, Okamoto R, Harada R, Takayama S, Kawai W, Kimura S, Ueki T, Okano N, Nakagawa M, Mizuno M, Araki Y, Shiratori Y. Regression of hepatocellular carcinoma during vitamin K administration. World J Gastroenterol 2005; 11(42): 6722-6724
URL: https://www.wjgnet.com/1007-9327/full/v11/i42/6722.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i42.6722